Amicus Pharma - Wutah bathi EPS kuartalan FOLD

Amicus Therapeutics (FOLD) develops high-margin drugs for rare metabolic pathologies, easily scaling production following the completion of R&D. The quarterly EPS dynamics on GURU.Markets show that -88.90 represents the latest metric reading. Profit growth is driven by expansion into underserved orphan niches, while financial success relies on Galafold sales and the successful rollout of Pombiliti.

Amicus Therapeutics, Inc. (FOLD) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan saka 04.07.2022 nganti 09.05.2026

Rincian metrik keuangan lan pasar Amicus Corp (FOLD)

- rega saham lan konsensus proyeksi valuasi:

Kutipan saham Amicus Therapeutics, Inc.|FOLD - Rega prakiraan analis

- rincian nilai pasar emiten:

Kapitalisasi pasar Amicus Pharma|FOLD - Nilai Perusahaan

- indikator nilai aset resik miturut neraca:

Nilai Buku saben Saham Amicus Therapeutics|FOLD - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku amicusrx.com|FOLD - Aset Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas Amicus Therapeutics|FOLD - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Amicus Therapeutics|FOLD - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Amicus Pharma|FOLD - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Amicus Therapeutics|Rasio cepet amicusrx.com

- indikator bathi lan kelipatan valuasi:

FOLD - Bathi resik|Bathi sing dikarepake Amicus Therapeutics|FOLD - Koefisien rega marang bathi|Pangali Forward P/E Amicus Pharma|FOLD - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Amicus Pharma|FOLD - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Amicus Therapeutics|FOLD - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan amicusrx.com|FOLD - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Amicus Therapeutics

Analisis kabeh metrik perusahaan:Amicus Therapeutics

Investors must evaluate the fundamental stability of Amicus Therapeutics (FOLD) through net income dynamics. This indicator measures the percentage change in earnings per share compared to the same quarter of the previous year. By analyzing the quarterly EPS movement, one can identify hidden margin compression or growth in efficiency. The stability of this metric confirms the success of the bioethical approach and the optimization of resources at Amicus Therapeutics (FOLD) laboratories. This demonstrates the link between ESG standards and financial returns.

Pesaing Amicus Therapeutics (FOLD)